Innocan Pharma Corp. buy EarningsForward40
Start price
22.01.25
/
50%
€0.11
Target price
22.02.25
-
Performance (%)
36.28%
End price
23.02.25
€0.15
Summary
This prediction ended on 23.02.25 with a price of €0.15. The BUY prediction by EarningsForward40 for Innocan Pharma Corp. saw massive gains of 36.28%. EarningsForward40 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Innocan Pharma Corp. | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% |
Comments by EarningsForward40 for this prediction
In the thread Trading Innocan Pharma Corp.
Die von EarningsForward40 gewählte maximale Laufzeit wurde überschritten